gdc
Submit Your Story Submit Your Art
Subscribe

Endometrial Cancer

Keytruda Monotherapy FDA Approved for Patients with Endometrial Carcinoma with a Biomarker
FDA Approvals, News & UpdatesEndometrial Cancer
Keytruda Monotherapy FDA Approved for Patients with Endometrial Carcinoma with a Biomarker
April 2022 Vol 8 No 2
Drugs for Endometrial (Uterine) Cancer
Endometrial Cancer
Drugs for Endometrial (Uterine) Cancer
2022 Patient Guide to Cancer Support Services
Find financial assistance programs available for endometrial (uterine) cancer drugs.
Jemperli First Immunotherapy FDA Approved for Endometrial Cancer with dMMR Biomarker
Endometrial CancerFDA Approvals, News & UpdatesImmunotherapy
Jemperli First Immunotherapy FDA Approved for Endometrial Cancer with dMMR Biomarker
July 2021 – Immunotherapy
In April 2021, the FDA approved Jemperli (dostarlimab-gxly) for patients with recurrent or advanced endometrial cancer and the biomarker mismatch repair-deficient. This is the first immunotherapy approved for patients with this type of cancer.

Results 1 - 3 of 3

Subscribe to CONQUER™: the patient voice™ magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest